Fontana Stefano, Groebli Rachel, Leibundgut Kurt, Pabst Thomas, Zwicky Caroline, Taleghani Behrouz Mansouri
Department of Hematology and Central Hematology Laboratory, Inselspital, University Hospital, Bern, Switzerland.
Transfusion. 2006 Aug;46(8):1408-16. doi: 10.1111/j.1537-2995.2006.00910.x.
Individual adaptation of processed patient's blood volume (PBV) should reduce number and/or duration of autologous peripheral blood progenitor cell (PBPC) collections.
The durations of leukapheresis procedures were adapted by means of an interim analysis of harvested CD34+ cells to obtain the intended yield of CD34+ within as few and/or short as possible leukapheresis procedures. Absolute efficiency (AE; CD34+/kg body weight) and relative efficiency (RE; total CD34+ yield of single apheresis/total number of preapheresis CD34+) were calculated, assuming an intraapheresis recruitment if RE was greater than 1, and a yield prediction models for adults was generated.
A total of 196 adults required a total of 266 PBPC collections. The median AE was 7.99 x 10(6), and the median RE was 1.76. The prediction model for AE showed a satisfactory predictive value for preapheresis CD34+ only. The prediction model for RE also showed a low predictive value (R2 = 0.36). Twenty-eight children underwent 44 PBPC collections. The median AE was 12.13 x 10(6), and the median RE was 1.62. Major complications comprised bleeding episodes related to central venous catheters (n = 4) and severe thrombocytopenia of less than 10 x 10(9) per L (n = 16).
A CD34+ interim analysis is a suitable tool for individual adaptation of the duration of leukapheresis. During leukapheresis, a substantial recruitment of CD34+ was observed, resulting in a RE of greater than 1 in more than 75 percent of patients. The upper limit of processed PBV showing an intraapheresis CD34+ recruitment is higher than in a standard large-volume leukapheresis. Therefore, a reduction of individually needed PBPC collections by means of a further escalation of the processed PBV seems possible.
对处理后的患者血容量(PBV)进行个体化调整应能减少自体外周血祖细胞(PBPC)采集的次数和/或时长。
通过对采集到的CD34+细胞进行中期分析来调整白细胞分离术的时长,以便在尽可能少和/或短的白细胞分离术过程中获得预期的CD34+产量。计算绝对效率(AE;CD34+/千克体重)和相对效率(RE;单次采集的总CD34+产量/采集前CD34+总数),如果RE大于1则假设存在采集过程中的细胞募集,并生成了成人的产量预测模型。
共有196名成年人共需要进行266次PBPC采集。AE中位数为7.99×10⁶,RE中位数为1.76。AE预测模型仅对采集前CD34+显示出令人满意的预测价值。RE预测模型的预测价值也较低(R² = 0.36)。28名儿童进行了44次PBPC采集。AE中位数为12.13×10⁶,RE中位数为1.62。主要并发症包括与中心静脉导管相关的出血事件(n = 4)以及严重血小板减少症(低于10×10⁹/L,n = 16)。
CD34+中期分析是用于个体化调整白细胞分离术时长的合适工具。在白细胞分离术中,观察到大量CD34+细胞募集,超过75%的患者RE大于1。显示采集过程中CD34+细胞募集的处理后PBV上限高于标准大容量白细胞分离术。因此,通过进一步增加处理后的PBV来减少个体所需的PBPC采集次数似乎是可行的。